StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences r&d expenses

Research and development expenses are spending on new products and technology.

Sight Sciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $10.85M, down 39.3% year over year. For fiscal 2025 it was $14.61M, down 18.8% from the year before. The highest annual figure on record is $22.86M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.61M-18.8%
FY2024Dec 31, 2024$17.99M+2.5%
FY2023Dec 31, 2023$17.56M-23.2%
FY2022Dec 31, 2022$22.86M+46.2%
FY2021Dec 31, 2021$15.63M+76.2%
FY2020Dec 31, 2020$8.87M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.51M-42.7%
Q1 FY2026Mar 31, 2026$2.55M-42.5%
Q4 FY2025Dec 31, 2025$2.44M-43.2%
Q3 FY2025Sep 30, 2025$3.35M-29.4%
Q2 FY2025Jun 30, 2025$4.39M+1.6%
Q1 FY2025Mar 31, 2025$4.43M-4.4%
Q4 FY2024Dec 31, 2024$4.29M+25.3%
Q3 FY2024Sep 30, 2024$4.75M+12.0%
Q2 FY2024Jun 30, 2024$4.32M-17.3%
Q1 FY2024Mar 31, 2024$4.64M-0.7%
Q4 FY2023Dec 31, 2023$3.43M-34.5%
Q3 FY2023Sep 30, 2023$4.24M-30.0%
Q2 FY2023Jun 30, 2023$5.22M-11.9%
Q1 FY2023Mar 31, 2023$4.67M-17.3%
Q4 FY2022Dec 31, 2022$5.23M+19.8%
Q3 FY2022Sep 30, 2022$6.05M+41.5%
Q2 FY2022Jun 30, 2022$5.93M+67.1%
Q1 FY2022Mar 31, 2022$5.65M+64.1%
Q4 FY2021Dec 31, 2021$4.37M+52.1%
Q3 FY2021Sep 30, 2021$4.28M+98.3%
Q2 FY2021Jun 30, 2021$3.55M+145.7%
Q1 FY2021Mar 31, 2021$3.44M–
Q4 FY2020Dec 31, 2020$2.87M–
Q3 FY2020Sep 30, 2020$2.16M–
Q2 FY2020Jun 30, 2020$1.44M–

More Sight Sciences figures

See a number that looks wrong?